Phase II Clinical Trial of a Granulocyte-Macrophage Colony-Stimulating Factor–Encoding, Second-Generation Oncolytic Herpesvirus in Patients With Unresectable Metastatic Melanoma As a result of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback